Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2007.092361v1, 2007; 10.1373/clinchem.2007.092361
This Article
Right arrow Full Text (PDF)
Right arrow 092361.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2007.092361v1
53/11/1891    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montgomery, J.
Right arrow Articles by Zhou, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montgomery, J.
Right arrow Articles by Zhou, L.

Received on May 20, 2007
Accepted on August 20, 2007

Molecular Diagnostics and Genetics

Scanning the Cystic Fibrosis Transmembrane Conductance Regulator Gene Using High-Resolution DNA Melting Analysis

Jesse Montgomery 1, Carl T. Wittwer 2*, Jana O. Kent 1, Luming Zhou 1

1 Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT
2 Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT, and ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT

* To whom correspondence should be addressed. E-mail: carl.wittwer{at}path.utah.edu.

Background: Complete gene analysis of the cystic fibrosis transmembrane conductance regulator gene (CFTR) by scanning and/or sequencing is seldom performed because of the cost, time, and labor involved. High-resolution DNA melting analysis is a rapid, closed-tube alternative for gene scanning and genotyping.

Methods: The 27 exons of CFTR were amplified in 37 PCR products under identical conditions. Common variants in 96 blood donors were identified in each exon by high-resolution melting on a LightScanner®. We then performed a subsequent blinded study on 30 samples enriched for disease-causing variants, including all 23 variants recommended by the American College of Medical Genetics and 8 additional, well-characterized variants.

Results: We identified 22 different sequence variants in 96 blood donors, including 4 novel variants and the disease-causing p.F508del. In the blinded study, all 40 disease-causing heterozygotes (29 unique) were detected, including 1 new probable disease-causing variant (c.3500-2A>T). The number of false-positive amplicons was decreased 96% by considering the 6 most common heterozygotes. The melting patterns of most heterozygotes were unique (37 of 40 pairs within the same amplicon), the exceptions being p.F508del vs p.I507del, p.G551D vs p.R553X, and p.W1282X vs c.4002A>G. The homozygotes p.G542X, c.2789 + 5G>A, and c.3849 + 10kbC>T were directly identified, but homozygous p.F508del was not. Specific genotyping of these exceptions, as well as genotyping of the 5T allele of intron 8, was achieved by unlabeled-probe and small-amplicon melting assays.

Conclusions: High-resolution DNA melting methods provide a rapid and accurate alternative for complete CFTR analysis. False positives can be decreased by considering the melting profiles of common variants.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Mol. Diagn.Home page
E. Lyon and C. T. Wittwer
LightCycler Technology in Molecular Diagnostics
J. Mol. Diagn., March 1, 2009; 11(2): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Zhou, R. J. Errigo, H. Lu, M. A. Poritz, M. T. Seipp, and C. T. Wittwer
Snapback Primer Genotyping with Saturating DNA Dye and Melting Analysis
Clin. Chem., October 1, 2008; 54(10): 1648 - 1656.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
M.-P. Audrezet, A. Dabricot, C. Le Marechal, and C. Ferec
Validation of High-Resolution DNA Melting Analysis for Mutation Scanning of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene
J. Mol. Diagn., September 1, 2008; 10(5): 424 - 434.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.